93 related articles for article (PubMed ID: 23531098)
1. Gender differences in colon cancer treatment.
Oliver JS; Martin MY; Richardson L; Kim Y; Pisu M
J Womens Health (Larchmt); 2013 Apr; 22(4):344-51. PubMed ID: 23531098
[TBL] [Abstract][Full Text] [Related]
2. Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis.
Sanoff HK; Carpenter WR; Freburger J; Li L; Chen K; Zullig LL; Goldberg RM; Schymura MJ; Schrag D
Cancer; 2012 Sep; 118(17):4309-20. PubMed ID: 22294436
[TBL] [Abstract][Full Text] [Related]
3. Use of Adjuvant Chemotherapy among Stage II Colon Cancer Patients in 10 Population-Based National Program of Cancer Registries.
Eheman CR; O'Neil ME; Styles TS; Thompson TD; Morris CR; Babcock FA; Chen VW
J Registry Manag; 2016; 43(4):179-186. PubMed ID: 29308117
[TBL] [Abstract][Full Text] [Related]
4. Construct validity of medicare chemotherapy claims: the case of 5FU.
Lamont EB; Lauderdale DS; Schilsky RL; Christakis NA
Med Care; 2002 Mar; 40(3):201-11. PubMed ID: 11880793
[TBL] [Abstract][Full Text] [Related]
5. Less-than-standard treatment in rectal cancer patients: which patients are at risk?
Pisu M; Richardson LC; Kim YI; Krontiras H; Martin MY; Salas M; Pollack LA
J Natl Med Assoc; 2010 Mar; 102(3):190-8. PubMed ID: 20355348
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of different chemotherapeutic regimens on survival of people aged 66 and older with stage III colon cancer: a "real world" analysis using Surveillance, Epidemiology, and End Results-Medicare data.
Hsiao FY; Mullins CD; Onukwugha E; Pandya N; Hanna N
J Am Geriatr Soc; 2011 Sep; 59(9):1717-23. PubMed ID: 21831168
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.
Sanoff HK; Carpenter WR; Martin CF; Sargent DJ; Meyerhardt JA; Stürmer T; Fine JP; Weeks J; Niland J; Kahn KL; Schymura MJ; Schrag D
J Natl Cancer Inst; 2012 Feb; 104(3):211-27. PubMed ID: 22266473
[TBL] [Abstract][Full Text] [Related]
8. Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia.
Gupta SK; Lamont EB
J Am Geriatr Soc; 2004 Oct; 52(10):1681-7. PubMed ID: 15450045
[TBL] [Abstract][Full Text] [Related]
9. Impact of race/ethnicity and socioeconomic status on adjuvant chemotherapy use among elderly patients with stage III colon cancer.
Hsieh MC; Chiu YW; Velasco C; Wu XC; O'Flarity MB; Chen VW
J Registry Manag; 2013; 40(4):180-7. PubMed ID: 24625772
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer.
Schrag D; Rifas-Shiman S; Saltz L; Bach PB; Begg CB
J Clin Oncol; 2002 Oct; 20(19):3999-4005. PubMed ID: 12351597
[TBL] [Abstract][Full Text] [Related]
11. Population-based study of the geographic variation in colon cancer incidence in Alabama: relationship to socioeconomic status indicators and physician density.
Shipp MP; Desmond R; Accortt N; Wilson RJ; Fouad M; Eloubeidi MA
South Med J; 2005 Nov; 98(11):1076-82. PubMed ID: 16353380
[TBL] [Abstract][Full Text] [Related]
12. Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer.
Sarasqueta C; Perales A; Escobar A; Baré M; Redondo M; Fernández de Larrea N; Briones E; Piera JM; Zunzunegui MV; Quintana JM;
BMC Cancer; 2019 Jul; 19(1):735. PubMed ID: 31345187
[TBL] [Abstract][Full Text] [Related]
13. Duration of adjuvant chemotherapy for colon cancer and survival among the elderly.
Neugut AI; Matasar M; Wang X; McBride R; Jacobson JS; Tsai WY; Grann VR; Hershman DL
J Clin Oncol; 2006 May; 24(15):2368-75. PubMed ID: 16618946
[TBL] [Abstract][Full Text] [Related]
14. Age and adjuvant chemotherapy use after surgery for stage III colon cancer.
Schrag D; Cramer LD; Bach PB; Begg CB
J Natl Cancer Inst; 2001 Jun; 93(11):850-7. PubMed ID: 11390534
[TBL] [Abstract][Full Text] [Related]
15. A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study.
Papadimitriou CA; Papakostas P; Karina M; Malettou L; Dimopoulos MA; Pentheroudakis G; Samantas E; Bamias A; Miliaras D; Basdanis G; Xiros N; Klouvas G; Bafaloukos D; Kafiri G; Papaspirou I; Pectasides D; Karanikiotis C; Economopoulos T; Efstratiou I; Korantzis I; Pisanidis N; Makatsoris T; Matsiakou F; Aravantinos G; Kalofonos HP; Fountzilas G
BMC Med; 2011 Jan; 9():10. PubMed ID: 21281463
[TBL] [Abstract][Full Text] [Related]
16. Geographic variation and sociodemographic disparity in the use of oxaliplatin-containing chemotherapy in patients with stage III colon cancer.
Panchal JM; Lairson DR; Chan W; Du XL
Clin Colorectal Cancer; 2013 Jun; 12(2):113-21. PubMed ID: 23137529
[TBL] [Abstract][Full Text] [Related]
17. Determinants of Variation in the Use of Adjuvant Chemotherapy for Stage III Colon Cancer in England.
Boyle JM; Kuryba A; Cowling TE; Aggarwal A; Hill J; van der Meulen J; Walker K; Braun MS
Clin Oncol (R Coll Radiol); 2020 May; 32(5):e135-e144. PubMed ID: 31926818
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer.
Brungs D; Aghmesheh M; de Souza P; Carolan M; Clingan P; Rose J; Ranson M
Clin Colorectal Cancer; 2018 Sep; 17(3):e549-e555. PubMed ID: 29861156
[TBL] [Abstract][Full Text] [Related]
19. The role of levamisole in the adjuvant treatment of stage III colon cancer patients: a randomized trial of 5-fluorouracil and levamisole versus 5-fluorouracil alone.
Cascinu S; Catalano V; Piga A; Mattioli R; Marcellini M; Pancotti A; Bascioni R; Torresi U; Silva RR; Pieroni V; Giorgi F; Catalano G; Cellerino R
Cancer Invest; 2003; 21(5):701-7. PubMed ID: 14628428
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy for stage II colon cancer with poor prognostic features.
O'Connor ES; Greenblatt DY; LoConte NK; Gangnon RE; Liou JI; Heise CP; Smith MA
J Clin Oncol; 2011 Sep; 29(25):3381-8. PubMed ID: 21788561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]